Cargando…
Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687667/ https://www.ncbi.nlm.nih.gov/pubmed/34942101 http://dx.doi.org/10.1016/S0140-6736(21)02844-0 |
| _version_ | 1784618219816878080 |
|---|---|
| author | Dejnirattisai, Wanwisa Shaw, Robert H Supasa, Piyada Liu, Chang Stuart, Arabella SV Pollard, Andrew J Liu, Xinxue Lambe, Teresa Crook, Derrick Stuart, Dave I Mongkolsapaya, Juthathip Nguyen-Van-Tam, Jonathan S Snape, Matthew D Screaton, Gavin R |
| author_facet | Dejnirattisai, Wanwisa Shaw, Robert H Supasa, Piyada Liu, Chang Stuart, Arabella SV Pollard, Andrew J Liu, Xinxue Lambe, Teresa Crook, Derrick Stuart, Dave I Mongkolsapaya, Juthathip Nguyen-Van-Tam, Jonathan S Snape, Matthew D Screaton, Gavin R |
| author_sort | Dejnirattisai, Wanwisa |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8687667 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86876672021-12-21 Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum Dejnirattisai, Wanwisa Shaw, Robert H Supasa, Piyada Liu, Chang Stuart, Arabella SV Pollard, Andrew J Liu, Xinxue Lambe, Teresa Crook, Derrick Stuart, Dave I Mongkolsapaya, Juthathip Nguyen-Van-Tam, Jonathan S Snape, Matthew D Screaton, Gavin R Lancet Correspondence Elsevier Ltd. 2022 2021-12-20 /pmc/articles/PMC8687667/ /pubmed/34942101 http://dx.doi.org/10.1016/S0140-6736(21)02844-0 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Dejnirattisai, Wanwisa Shaw, Robert H Supasa, Piyada Liu, Chang Stuart, Arabella SV Pollard, Andrew J Liu, Xinxue Lambe, Teresa Crook, Derrick Stuart, Dave I Mongkolsapaya, Juthathip Nguyen-Van-Tam, Jonathan S Snape, Matthew D Screaton, Gavin R Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum |
| title | Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum |
| title_full | Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum |
| title_fullStr | Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum |
| title_full_unstemmed | Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum |
| title_short | Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum |
| title_sort | reduced neutralisation of sars-cov-2 omicron b.1.1.529 variant by post-immunisation serum |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687667/ https://www.ncbi.nlm.nih.gov/pubmed/34942101 http://dx.doi.org/10.1016/S0140-6736(21)02844-0 |
| work_keys_str_mv | AT dejnirattisaiwanwisa reducedneutralisationofsarscov2omicronb11529variantbypostimmunisationserum AT shawroberth reducedneutralisationofsarscov2omicronb11529variantbypostimmunisationserum AT supasapiyada reducedneutralisationofsarscov2omicronb11529variantbypostimmunisationserum AT liuchang reducedneutralisationofsarscov2omicronb11529variantbypostimmunisationserum AT stuartarabellasv reducedneutralisationofsarscov2omicronb11529variantbypostimmunisationserum AT pollardandrewj reducedneutralisationofsarscov2omicronb11529variantbypostimmunisationserum AT liuxinxue reducedneutralisationofsarscov2omicronb11529variantbypostimmunisationserum AT lambeteresa reducedneutralisationofsarscov2omicronb11529variantbypostimmunisationserum AT crookderrick reducedneutralisationofsarscov2omicronb11529variantbypostimmunisationserum AT stuartdavei reducedneutralisationofsarscov2omicronb11529variantbypostimmunisationserum AT mongkolsapayajuthathip reducedneutralisationofsarscov2omicronb11529variantbypostimmunisationserum AT nguyenvantamjonathans reducedneutralisationofsarscov2omicronb11529variantbypostimmunisationserum AT snapematthewd reducedneutralisationofsarscov2omicronb11529variantbypostimmunisationserum AT screatongavinr reducedneutralisationofsarscov2omicronb11529variantbypostimmunisationserum AT reducedneutralisationofsarscov2omicronb11529variantbypostimmunisationserum |